News and Events
How To Break Through the Barriers Facing Biosimilars
The Cost Conundrum of GLP-1s and Their Impact on Pharmacy Spend
Pharmacy Times Part 2: What Went Wrong – How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars
Chief Pharmacy Officer, Mark Campbell Featured in Pharmacy Times
Meet Our Experts: Annette Sanjines and Norm Puente
Featured in Pharmacy Times: How to Tame the Rising Cost of Medications
Mark Campbell Featured in BenefitsPro Article: Managing the Financial Side Effects of Specialty Drugs
RxBenefits Appoints Sara Epstein as Chief Legal Officer
Get Our Newsletter
Stay informed with expert advice and actionable insights to optimize pharmacy benefits, reduce costs and enhance member care.
